This product is a blood lipid regulating drug of clofibric acid derivatives. Its mechanism of lowering blood lipids is not yet fully understood. It may reduce the cAMP content in liver microsomes, increase the activity of lipoprotein esterase, and decompose lipids in lipoproteins. Experimental and clinical studies have shown that this product reduces blood cholesterol and triglycerides and increases blood high-density lipoprotein. In addition, this product also has anti-platelet aggregation and anti-thrombotic effects and reduces blood uric acid.

This product is an antibiotic with broad-spectrum antibacterial effect and is suitable for skin inflammation caused by Gram-positive or Gram-positive bacteria.

This product is a central anticholinergic anti-Parkinson's disease drug that selectively blocks the cholinergic nerve pathways in the striatum, but has less effect on the periphery, thus helping to restore the balance of dopamine and acetylcholine in the brain of Parkinson's patients and improve the patients' Parkinson's disease symptoms.

This product is a calcium channel blocker, which can prevent cell damage caused by pathological intracellular calcium overload due to ischemia and other reasons; 1. Relieve vasospasm, and have a lasting inhibitory effect on persistent vasospasm caused by vasoconstrictor substances, especially on the basilar artery and internal carotid artery; 2. Vestibular inhibitory effect, which can increase blood flow in the cochlear arterioles and improve vestibular organ circulation; 3. Anti-epileptic effect, which can block pathological calcium overload of nerve cells to prevent paroxysmal depolarization and cell discharge, thereby avoiding epileptic seizures; 4. Protect the myocardium and significantly reduce ischemic myocardial damage; 5. Improve renal function and can be used for chronic renal failure; In addition, this product also has anti-histamine effect.